Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETV, TQ-A3334 and TQ-B2450 in Chronic Hepatitis B
NCT04202653Phase 2Completed
- Sponsor
- Tongji Hospital
- Start
- Jan 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tq-a3334, benmelstobart in Chronic Hepatitis B (CHB), sponsored by Tongji Hospital. Started Jan 2020; status: completed.
02
Drugs
tq-a3334benmelstobart
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04202653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04202653.